Skip to main content

Table 1 General characteristics of study participants

From: The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

 

Placebo group (n = 30)

Synbiotic group (n = 30)

pa

Age (y)

25.9 ± 5.2

25.7 ± 5.5

0.90

Height (cm)

163.3 ± 6.6

161.4 ± 5.8

0.25

Weight at study baseline (kg)

72.4 ± 14.1

71.4 ± 11.6

0.79

Weight at end-of-trial (kg)

71.9 ± 14.4

71.2 ± 11.4

0.83

Weight change (kg)

−0.4 ± 1.0

− 0.3 ± 1.2

0.53

BMI at study baseline (kg/m2)

27.2 ± 5.3

27.4 ± 4.0

0.84

BMI at end-of-trial (kg/m2)

27.0 ± 5.4

27.3 ± 3.9

0.80

BMI change (kg/m2)

−0.2 ± 0.3

− 0.1 ± 0.4

0.49

MET-h/day at study baseline

27.5 ± 2.0

27.7 ± 2.1

0.60

MET-h/day at end-of-trial

27.6 ± 2.2

27.8 ± 2.3

0.69

MET-h/day change

0.1 ± 0.6

0.04 ± 1.0

0.83

  1. Data are means± SDs
  2. aObtained from independent t test. METs, metabolic equivalents